Related Experiment Video
Updated: May 21, 2025

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway
Nishant Patidar1, Archana M Navale1, Nitesh Parsaila1
1Department of Pharmacology, Parul Institute of Pharmacy, Parul University Limda, Vadodara, Gujarat, India.
Abstract:
Nicotine addiction is a complex phenomenon entwined with intricate mechanisms within the nicotine receptor pathway. This review offers an insightful exploration of this multifaceted landscape, delving into the interplay between nicotinic acetylcholine receptors (nAChRs) and their pivotal role in neurotransmission. The structural and functional aspects of nAChRs, their distribution within the peripheral and central nervous systems, and their involvement in modulating diverse signalling cascades are reviewed. The clinical implications of nicotine addiction and the challenges in smoking cessation are also explored. Nicotine Replacement Therapy (NRT) drugs, designed to alleviate withdrawal symptoms and aid in smoking cessation, are critically evaluated. This article synthesizes current research findings on the efficacy, safety, and limitations of various NRT modalities. Furthermore, emerging pharmacotherapeutic strategies and novel molecules aimed at optimizing NRT outcomes are discussed. The potential of leveraging a deeper understanding of the nicotine receptor pathway to develop more targeted and efficacious NRT interventions is emphasized. The exploration of adjunct therapies and combination approaches to enhance the success rates of smoking cessation is also addressed. Through a synthesis of preclinical and clinical evidence, this article aims to provide a comprehensive resource for researchers, clinicians, and policymakers working towards advancing the field of nicotine addiction treatment. As the global effort to combat tobacco-related health challenges intensifies, a nuanced understanding of the nicotine receptor pathway and its therapeutic implications becomes increasingly imperative.
More Related Videos
10:04Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
10:48Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
Published on: January 25, 2019
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...